Two Sigma Investments’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $529K | Sell |
941
-6,000
| -86% | -$3.85M | ﹤0.01% | 3707 |
|
|
2025
Q4 | $4.7M | Sell |
6,941
-2,759
| -28% | -$1.88M | 0.01% | 1766 |
|
|
2025
Q3 | $6.2M | Hold |
9,700
| – | – | 0.01% | 1292 |
|
|
2025
Q2 | $5.2M | Sell |
9,700
-24,639
| -72% | -$11.8M | 0.01% | 1206 |
|
|
2025
Q1 | $14.4M | Sell |
34,339
-53,147
| -61% | -$23.1M | 0.03% | 613 |
|
|
2024
Q4 | $36.2M | Sell |
87,486
-24,214
| -22% | -$10.6M | 0.08% | 313 |
|
|
2024
Q3 | $56.4M | Buy |
111,700
+59,908
| +116% | +$29.1M | 0.12% | 202 |
|
|
2024
Q2 | $25.2M | Buy |
51,792
+6,611
| +15% | +$3.32M | 0.06% | 381 |
|
|
2024
Q1 | $24.4M | Buy |
45,181
+27,248
| +152% | +$14.9M | 0.06% | 382 |
|
|
2023
Q4 | $9.95M | Sell |
17,933
-80,987
| -82% | -$38M | 0.02% | 683 |
|
|
2023
Q3 | $43.3M | Buy |
+98,920
| New | +$49.3M | 0.12% | 223 |
|
|
2023
Q1 | – | Sell |
-536
| Closed | -$219K | – | 3069 |
|
|
2022
Q4 | $219K | Sell |
536
-80,338
| -99% | -$31.2M | ﹤0.01% | 2363 |
|
|
2022
Q3 | $26.3M | Sell |
80,874
-26,749
| -25% | -$9.83M | 0.09% | 266 |
|
|
2022
Q2 | $37.7M | Buy |
+107,623
| New | +$43.9M | 0.12% | 194 |
|
|
2022
Q1 | – | Sell |
-22,108
| Closed | -$14.6M | – | 3421 |
|
|
2021
Q4 | $14.6M | Buy |
22,108
+18,633
| +536% | +$11.7M | 0.03% | 605 |
|
|
2021
Q3 | $2.16M | Buy |
+3,475
| New | +$2.34M | ﹤0.01% | 1920 |
|
|
2020
Q2 | – | Sell |
-3,293
| Closed | -$953K | – | 3202 |
|
|
2020
Q1 | $798K | Sell |
3,293
-47,500
| -94% | -$12.4M | 0.01% | 1593 |
|
|
2019
Q4 | $13.3M | Buy |
+50,793
| New | +$13.4M | 0.04% | 508 |
|
|
2019
Q1 | – | Sell |
-31,835
| Closed | -$6.57M | – | 3233 |
|
|
2018
Q4 | $5.92M | Buy |
31,835
+11,434
| +56% | +$2.34M | 0.02% | 727 |
|
|
2018
Q3 | $5.09M | Sell |
20,401
-221,191
| -92% | -$53.7M | 0.01% | 939 |
|
|
2018
Q2 | $52.7M | Sell |
241,592
-107,145
| -31% | -$22.1M | 0.16% | 168 |
|
|
2018
Q1 | $66.7M | Buy |
348,737
+166,052
| +91% | +$30.6M | 0.22% | 118 |
|
|
2017
Q4 | $28.6M | Sell |
182,685
-105,410
| -37% | -$16.6M | 0.09% | 287 |
|
|
2017
Q3 | $44.8M | Sell |
288,095
-77,108
| -21% | -$12.2M | 0.16% | 168 |
|
|
2017
Q2 | $59M | Sell |
365,203
-300,227
| -45% | -$48.8M | 0.21% | 115 |
|
|
2017
Q1 | $103M | Buy |
665,430
+516,757
| +348% | +$71.2M | 0.35% | 48 |
|
|
2016
Q4 | $17.4M | Sell |
148,673
-299,765
| -67% | -$34.2M | 0.07% | 349 |
|
|
2016
Q3 | $50.6M | Sell |
448,438
-95,545
| -18% | -$10.1M | 0.18% | 121 |
|
|
2016
Q2 | $50.5M | Buy |
543,983
+154,955
| +40% | +$13.3M | 0.22% | 104 |
|
|
2016
Q1 | $30.5M | Buy |
+389,028
| New | +$28M | 0.15% | 167 |
|
|
2015
Q2 | – | Sell |
-3,526
| Closed | -$272K | – | 2926 |
|
|
2015
Q1 | $272K | Buy |
+3,526
| New | +$274K | ﹤0.01% | 2324 |
|
|
2014
Q4 | – | Sell |
-184,618
| Closed | -$10.9M | – | 2291 |
|
|
2014
Q3 | $10.9M | Buy |
184,618
+164,150
| +802% | +$10.4M | 0.05% | 422 |
|
|
2014
Q2 | $1.37M | Sell |
20,468
-69,850
| -77% | -$4.44M | 0.01% | 1176 |
|
|
2014
Q1 | $5.48M | Sell |
90,318
-179,190
| -66% | -$10.7M | 0.03% | 599 |
|
|
2013
Q4 | $14.3M | Buy |
269,508
+262,778
| +3,905% | +$13.8M | 0.08% | 326 |
|
|
2013
Q3 | $335K | Hold |
6,730
| – | – | ﹤0.01% | 1453 |
|
|
2013
Q2 | $302K | Buy |
+6,730
| New | +$294K | ﹤0.01% | 1625 |
|
Other funds holding IDXX
VCM
VPM
Two Sigma Investments's IDXX Position: Q1 2026 in Review
Two Sigma Investments reduced its Idexx Laboratories (IDXX) stake by 86% in Q1 2026, selling an estimated $3.85M and leaving 941 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #3707.
Two Sigma Investments first reported a position in IDXX in Q2 2013 and has held it in 37 quarters since. The position peaked at $103M in Q1 2017. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Two Sigma Investments held 941 shares of Idexx Laboratories worth $529K as of Q1 2026.
- Two Sigma Investments sold 6,000 Idexx Laboratories shares in Q1 2026, an estimated $3.85M.
- Idexx Laboratories made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3707 holding.
- Two Sigma Investments first reported a position in Idexx Laboratories in Q2 2013 and has held it in 37 quarters since.
- Two Sigma Investments's Idexx Laboratories position peaked at $103M in Q1 2017.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.